Innovative Clinical Solutions is categorized under Medical Labs in New York City, NY and active since 2008.
Innovative Clinical Solutions was established in 2008, and today employs 1 to 4, earning $1.000.000 to $2.499.999 per year. This is a Medical Labs business, which does work in the B2C market, and is classified as a Medical Labs, under code number 6215110 by the NAICS.
If you are seeking more information, feel free to contact Michael Schulman, Principal at the company’s single location by writing to 250 East 87th St Apartment 21e, New York City, New York NY 10128 or by phoning (212) 686-1008. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Innovative Clinical Solutions |
| Contact Person: | Michael Schulman, Principal |
| Address: | 250 East 87th St Apartment 21e, New York City, New York 10128 |
| Phone Number: | (212) 686-1008 |
| Annual Revenue (USD): | $1.000.000 to $2.499.999 |
| Founded: | 2008 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | Medical Labs |
| SIC Code: | 8071 |
| NAICS Code: | 6215110 |
| Share This Business: |
Innovative Clinical Solutions was started in 2008 to provide professional Medical Labs under the SIC code 8071 and NAICS code 6215110. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $1.000.000 to $2.499.999 per annum.
Feel free to contact Michael Schulman, Principal for inquiries that concern Innovative Clinical Solutions by calling the company number (212) 686-1008, as your correspondence is most welcome. Additionally, the physical location of the single location of Innovative Clinical Solutions can be found at the coordinates 40.779056,-73.952237 as well as the street address 250 East 87th St Apartment 21e in New York City, New York 10128.
For its online presence, you may visit Innovative Clinical Solutions’s website at and engage with its social media outlets through on Twitter and on Facebook.